| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | 3 | — | 4 | — | — | 2 | 4 | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.97 |
—
—
—
|
| 2025 | 0.05 |
—
—
—
—
|
| 2024 | 0.88 |
—
—
—
—
|
| 2023 | 0.50 |
—
—
—
—
|
| 2022 | 0.01 |
—
|
| 2021 | 0.03 |
—
|
| 2020 | 1.01 |
—
—
—
—
—
|
| 2019 | 1.05 |
—
—
—
—
—
—
—
—
|
| 2018 | 0.80 |
—
—
—
—
—
—
—
—
|
| 2017 | 1.06 |
—
—
—
—
—
—
—
—
|
| 2016 | 1.05 |
—
—
—
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 14.71 | 23.23 | 43.58 | 46.66 |
| Receivables | 5.79 | 6.64 | 7.60 | 6.29 |
| Inventory | 19.89 | 19.24 | 17.84 | 26.58 |
| Other | 4.28 | — | — | — |
| 44.68 | 53.24 | 75.16 | 90.12 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1.21 | 3.75 | 2.64 | 3.10 |
| ST’ Debt | — | — | — | — |
| Other | 8.08 | 9.04 | 22.89 | 33.49 |
| 11.48 | 15.27 | 28.27 | 39.59 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | 9.09 | 12.14 | 11.42 | — |
—
|
| ’25 | 10.44 | 13.61 | 10.30 | 9.60 |
43.95
|
| ’24 | 8.57 | 10.30 | 8.25 | 11.61 |
38.74
|
| ’23 | 8.64 | 8.80 | 9.81 | 8.34 |
35.59
|
| ’22 | 7.55 | 7.46 | 8.62 | 8.48 |
32.10
|
| ’21 | 7.27 | 6.96 | 4.21 | 9.30 |
27.73
|
| ’20 | 5.92 | 7.29 | 6.19 | 12.12 |
31.53
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | 5.72 | (2.81) | 3.39 | — |
—
|
| ’25 | 1.39 | 5.38 | 11.45 | 2.77 |
20.99
|
| ’24 | 2.61 | 3.32 | 1.41 | 3.24 |
10.60
|
| ’23 | 0.97 | 3.71 | 2.38 | (3.16) |
3.90
|
| ’22 | 1.59 | (1.31) | 0.53 | 1.41 |
2.22
|
| ’21 | 1.38 | 1.55 | (0.74) | (1.59) |
0.60
|
| ’20 | 3.73 | 2.27 | (1.07) | 1.03 |
5.97
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | 4.43 | (4.13) | 3.20 | — |
—
|
| ’25 | 0.72 | 4.49 | 10.49 | 0.92 |
16.63
|
| ’24 | 0.39 | 2.08 | 0.38 | 2.58 |
5.43
|
| ’23 | 0.92 | 3.66 | 2.31 | (3.50) |
3.39
|
| ’22 | 1.54 | (1.36) | 0.42 | 1.32 |
1.92
|
| ’21 | 1.36 | 1.54 | (0.75) | (1.60) |
0.55
|
| ’20 | 3.64 | 2.19 | (1.10) | 1.03 |
5.75
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | 0.76 | 0.99 | 0.99 | — |
—
|
| ’25 | 0.61 | 0.71 | 0.63 | 1.05 |
3.02
|
| ’24 | 0.44 | 0.72 | 0.40 | 0.73 |
2.29
|
| ’23 | 0.31 | 0.47 | 0.35 | 0.36 |
1.49
|
| ’22 | 0.13 | 0.01 | 0.27 | 0.11 |
0.52
|
| ’21 | 0.08 | (0.08) | (0.44) | 0.36 |
(0.08)
|
| ’20 | 0.03 | 0.10 | (0.04) | 0.40 |
0.49
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.39 | 14.17 | 17.97 | 24.85 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 15.79 | 22.96 | 33.00 | 55.00 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 150 | 153 | 148 | 152 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.21 | 0.23 | 0.26 | 0.29 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.10 | 35.59 | 38.74 | 43.95 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.04% | 22.62% | 27.50% | 28.86% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.59 | 4.71 | 7.30 | 9.73 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.96% | 13.22% | 18.83% | 22.14% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.27 | 3.68 | 5.82 | 8.14 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.49 | 0.48 | 0.45 | 0.45 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.20 | 14.50 | 15.56 | 16.96 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 0.52 | 1.50 | 2.34 | 3.14 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.91 | 1.59 | 4.26 | 8.10 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.12) | (0.21) | (2.07) | (1.68) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.79 | 1.38 | 2.18 | 6.42 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.20 | 14.62 | 16.58 | 19.63 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.43 | 2.45 | 2.49 | 2.59 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 27.38 | 11.17 | 9.23 | 14.60 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.08 | 1.16 | 1.38 | 2.69 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.08 | 1.15 | 1.30 | 2.33 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.71 | 0.74 | 0.78 | 1.70 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.90 | 7.79 | 5.58 | 4.50 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.22 | 3.90 | 10.60 | 20.99 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.30) | (0.51) | (5.16) | (4.37) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.92 | 3.39 | 5.43 | 16.63 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 29.48 | 33.19 | 37.97 | 46.89 | — | — | — |
Working Cap'
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (11.81) | (14.71) | (23.23) | (43.58) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.10 | 35.88 | 41.27 | 50.85 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.25% | 8.41% | 11.18% | 12.01% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.71% | 12.70% | 22.65% | 69.87% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.05% | 10.82% | 15.07% | 17.68% | — | — | — |
ROE
|
Espey Mfg. & Electronics Corp. (ESP) emerges as a steadfast contender in military power electronics, thriving amid escalating geopolitical tensions, U.S. defense modernization, and surging budgets post-Ukraine invasion. Over the past decade, revenue has compounded at 41% from $27.5 million in 2016 to $38.7 million in 2024, with per-employee productivity up 38% despite stable headcount, signaling superior efficiency and pricing power. Gross margins have rebounded 127% from pandemic lows to 27.5%, driving EBT margins to a projected 22.1% in 2025 and net income toward $13.4 million by 2028.
A debt-free balance sheet, ballooning net cash to $43.6 million, and explosive free cash flow growth (194% to $6.42 per share in 2025) underpin this momentum, fueling ROE to 17.7% and ROIC to nearly 70%. Analysts forecast revenue rocketing 49% to $65.8 million in 2026, with EPS surging 51% to $4.75, yet the stock trades at undemanding 14-15x forward earnings, 2.7x sales, and 4.5x EV/FCF—implying 22% upside to consensus targets and significant catch-up potential.
While insider sells totaling $1.1 million raise a cautious flag, ESP’s MIL-STD certified edge in hypersonics, defense EVs, and railguns positions it for trillion-dollar tailwinds through 2030. This undervalued innovator in a disrupted sector warrants close scrutiny for long-term compounding.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.